English
+38 068 889 89 89
00380689869898 (汉语)
00380930552240 (باللغة العربية)
00380930552240 (باللغة العربية)
+38 044 223 28 95
Contact us

Fetal stem cells are effective in the treatment of Grade Ⅰ and Ⅱ respiratory failure in amyotrophic lateral sclerosis and muscular dystrophy

As our study shows, fetal stem cell treatment improved both subjective and objective breathing parameters as early as 6 months post‐treatment in patients wirh respiratory failure. A significant increase in the forced vital capacity and forced expiratory volume in 1 second was reported by all patients with grade Ⅰ respiratory failure linked to ALS and MD compared to baseline. Patient respiratory improvement was maintained over the next 6 months. Grade Ⅱ RF patients with MD reported a significant improvement in FVC 12 months after treatment.

Read more:
Nataliia S. Sych, Olena V. Ivankova , Mariya O. Klunnyk, Iryna G. Matiyashchuk, Andrey A. Sinelnyk, Mariya P. Demchyk, Maryna V. Skalozyb, Dario Siniscalco. Fetal stem cells are effective in the treatment of Grade Ⅰ and Ⅱ respiratory failure in amyotrophic lateral sclerosis and muscular dystrophy. // Translational Neuroscience and Clinics. – September 2015. – No. 1 Vol. 1, pp. 10–16.


Fetal stem cells treatment results depend on: disease's severity, age of the patient, adherence for the medications and regime. Treatment results, presented on this site, are individual for each clinical case.